NCT01944683View on ClinicalTrials.gov

A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

July 31, 2016

Conditions
Heart Failure
Interventions
OTHER

Placebo

DRUG

GGF2

DRUG

Midazolam

Trial Locations (8)

23507

Sentara Cardiovascular Research Institute, Norfolk

27710

Duke Clinical Research Unit, Durham

32216

Jacksonville Center for Clinical Research, Jacksonville

37232

Vanderbilt University Medical Center, Nashville

37920

New Orleans Center for Clinical Research (NOCCR), Knoxville

70112

Tulane University School of Medicine, New Orleans

92037

UCSD Medical Center, La Jolla

92780

Orange County Research Center, Tustin

Sponsors
All Listed Sponsors
lead

Acorda Therapeutics

INDUSTRY

NCT01944683 - A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure | Biotech Hunter | Biotech Hunter